tDCS + Cognitive Training for Fetal Alcohol Spectrum Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help children and teens with Fetal Alcohol Spectrum Disorders (FASD), a condition caused by prenatal alcohol exposure. Researchers aim to determine if combining cognitive training exercises with transcranial direct current stimulation (tDCS) can enhance brain function. Participants will receive either active tDCS (a non-invasive brain stimulation technique) or a sham version, alongside cognitive training. Ideal candidates are children and teens, ages 8 to 17, with confirmed prenatal alcohol exposure and a diagnosis related to FASD. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could shape future treatments for FASD.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that transcranial direct current stimulation (tDCS) and cognitive training are safe for children and adolescents with prenatal alcohol exposure?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe for children with fetal alcohol spectrum disorders (FASD). When combined with exercises to improve thinking skills, tDCS is usually safe and can be more effective than the exercises alone. Studies have not identified any major harmful side effects, indicating that this treatment is safe for children and teens exposed to alcohol before birth.
The thinking exercises alone are also safe and have been widely used to enhance learning and thinking skills. When paired with tDCS, study results are promising for both safety and effectiveness.
Overall, both treatments in this trial have demonstrated safety and good tolerance in similar groups of children.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it combines two innovative approaches—transcranial Direct Current Stimulation (tDCS) and cognitive training—to potentially enhance brain function in individuals with Fetal Alcohol Spectrum Disorders (FASD). Unlike standard treatments that often focus on managing symptoms through behavioral therapy and medication, this trial explores the direct stimulation of the brain to improve executive functioning. By applying a mild electrical current to the brain while simultaneously engaging in cognitive exercises, this method aims to boost neural activity and cognitive skills more effectively. This combination could offer a more targeted and potentially faster improvement in cognitive abilities compared to traditional therapies.
What evidence suggests that this trial's treatments could be effective for Fetal Alcohol Spectrum Disorders?
Research has shown that transcranial direct current stimulation (tDCS) combined with brain exercises can enhance brain function in children with fetal alcohol spectrum disorders (FASD). In this trial, participants will receive either active tDCS with cognitive training or sham tDCS with cognitive training. Studies have found that tDCS, when paired with these exercises, offers more benefits than the exercises alone. This combination is safe for children. Additionally, brain exercises alone can improve thinking skills and everyday functioning in children. These findings suggest that using both tDCS and brain exercises together might effectively help children and teenagers exposed to alcohol before birth improve their cognitive skills.12356
Who Is on the Research Team?
Jeffrey R Wozniak, Ph.D.
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for children and teens aged 8-17 with Fetal Alcohol Spectrum Disorders (FASD) due to heavy prenatal alcohol exposure. They need a parent or guardian to consent. It's not for those with substance abuse, other developmental disorders, serious psychiatric conditions affecting the brain, very low birthweight, or who can't have MRI or tDCS.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline visit with cognitive testing
Treatment
5 sessions of cognitive training with tDCS (active or sham)
Follow-up
Participants are monitored for changes in cognitive performance
What Are the Treatments Tested in This Trial?
Interventions
- Active tDCS
- Cognitive Training
- Sham tDCS
Active tDCS is already approved in United Kingdom, Brazil for the following indications:
- Depression
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor